{"slideshow_credits": null, "snippet": "The biggest of the proxy advisory firms wrote in a report that Illumina shareholders should re-elect all of the company's proposed directors, instead of voting for director candidates proposed by Roche.", "abstract": "The biggest of the proxy advisory firms wrote in a report that Illumina shareholders should re-elect all of the company's proposed directors, instead of voting for director candidates proposed by Roche.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "DE LA MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. DE LA MERCED"}, "web_url": "http://dealbook.nytimes.com/2012/04/06/i-s-s-sides-with-illumina-in-proxy-fight-against-roche/", "lead_paragraph": null, "headline": {"main": "I.S.S. Sides With Illumina in Proxy Fight Against Roche", "kicker": "DealBook"}, "_id": "4fd3a4488eb7c8105d8eeb26", "word_count": "655", "multimedia": [], "pub_date": "2012-04-06T10:33:43Z", "source": "The New York Times", "news_desk": null, "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}